March 5(Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
* Says co’s unit Guangzhou Baiyunshan Tianxin Pharmaceutical Co Ltd received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration, for powder-injection, small-volume injection, tablet, hard capsule, dry suspension and granule
* Says the valid period is until Feb. 22, 2023
Source text in Chinese: goo.gl/Zqxrkh
Further company coverage: (Beijing Headline News)
Our Standards: The Thomson Reuters Trust Principles.